Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganyan-1 in Dry Eye
NCT06818487Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jul 2025
- Primary completion
- Jan 2027
01
Overview
Randomised, triple-blind trial of Ganyan-1 in dry eye disease (DED) (3 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Ocular Surface Disease Index at 16 weeks. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
Ganyan-1
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06818487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06818487.